These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38274229)
41. Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses. Zhang W; Ma L; Zhou Q; Gu T; Zhang X; Xing H Diabetes; 2024 Apr; 73(4):618-627. PubMed ID: 38211557 [TBL] [Abstract][Full Text] [Related]
42. Investigating potential novel therapeutic targets and biomarkers for ankylosing spondylitis using plasma protein screening. You W; Lin Y; Liu M; Lin Z; Ye R; Zhang C; Zeng R Front Immunol; 2024; 15():1406041. PubMed ID: 39185422 [TBL] [Abstract][Full Text] [Related]
43. Mitochondrial dysfunction and onset of type 2 diabetes along with its complications: a multi-omics Mendelian randomization and colocalization study. Li Y; Miao Y; Feng Q; Zhu W; Chen Y; Kang Q; Wang Z; Lu F; Zhang Q Front Endocrinol (Lausanne); 2024; 15():1401531. PubMed ID: 39280009 [TBL] [Abstract][Full Text] [Related]
44. Causal influence of immune factors on the risk of diabetic retinopathy: a mendelian randomization study. Li Y; Xiang Y; Mou B; Song X Diabetol Metab Syndr; 2024 Aug; 16(1):194. PubMed ID: 39135059 [TBL] [Abstract][Full Text] [Related]
45. Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses. Yuan S; Xu F; Li X; Chen J; Zheng J; Mantzoros CS; Larsson SC Cell Rep Med; 2023 Sep; 4(9):101174. PubMed ID: 37652020 [TBL] [Abstract][Full Text] [Related]
46. Rheumatoid arthritis and diabetic retinopathy: A two-sample Mendelian randomization study. Zeng Y; Mo G; Wang Z; Wang X; Li K; Yang Y; Tian N Medicine (Baltimore); 2024 Jul; 103(30):e39001. PubMed ID: 39058858 [TBL] [Abstract][Full Text] [Related]
47. Genetically Determined Chronic Low-Grade Inflammation and Hundreds of Health Outcomes in the UK Biobank and the FinnGen Population: A Phenome-Wide Mendelian Randomization Study. Si S; Li J; Tewara MA; Xue F Front Immunol; 2021; 12():720876. PubMed ID: 34386016 [TBL] [Abstract][Full Text] [Related]
48. The association of alanine aminotransferase and diabetic microvascular complications: A Mendelian randomization study. Bi Y; Liu Y; Wang H; Tian S; Sun C Front Endocrinol (Lausanne); 2023; 14():1104963. PubMed ID: 36742400 [TBL] [Abstract][Full Text] [Related]
49. Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis. Zou M; Shao Z Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540773 [TBL] [Abstract][Full Text] [Related]
50. Utilize proteomic analysis to identify potential therapeutic targets for combating sepsis and sepsis-related death. Zhang T; Shi Y; Li J; Huang P; Chen K; Yao J Front Endocrinol (Lausanne); 2024; 15():1448314. PubMed ID: 39387050 [TBL] [Abstract][Full Text] [Related]
51. Elucidating the role of genetically determined metabolites in Diabetic Retinopathy: insights from a mendelian randomization analysis. Tan Y; Yan Z; Yin J; Cao J; Xie B; Zhang F; Zhang W; Xiong W Acta Diabetol; 2024 Aug; ():. PubMed ID: 39090426 [TBL] [Abstract][Full Text] [Related]
52. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome. Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196 [TBL] [Abstract][Full Text] [Related]
53. Identification of drug targets for Sjögren's syndrome: multi-omics Mendelian randomization and colocalization analyses. Bai Y; Wang J; Feng X; Xie L; Qin S; Ma G; Zhang F Front Immunol; 2024; 15():1419363. PubMed ID: 38933282 [TBL] [Abstract][Full Text] [Related]
54. Pinpointing Novel Plasma and Brain Proteins for Common Ocular Diseases: A Comprehensive Cross-Omics Integration Analysis. Mo Q; Liu X; Gong W; Wang Y; Yuan Z; Sun X; Wang S Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408566 [TBL] [Abstract][Full Text] [Related]
55. Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis. Su Z; Wan Q Front Immunol; 2024; 15():1342912. PubMed ID: 38707900 [TBL] [Abstract][Full Text] [Related]
56. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma. Zhang L; Xiong Y; Zhang J; Feng Y; Xu A J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019 [TBL] [Abstract][Full Text] [Related]
57. No bidirectional relationship between sleep phenotypes and risk of proliferative diabetic retinopathy: a two-sample Mendelian randomization study. Liu H; Li L; Zan X; Wei J Sci Rep; 2024 Apr; 14(1):9585. PubMed ID: 38671284 [TBL] [Abstract][Full Text] [Related]
58. Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases. Li J; Ma X; Yin C Sci Rep; 2024 May; 14(1):11814. PubMed ID: 38782984 [TBL] [Abstract][Full Text] [Related]
59. Potential drug targets for tumors identified through Mendelian randomization analysis. Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700 [TBL] [Abstract][Full Text] [Related]
60. Mendelian Randomization and Bayesian Colocalization Analysis Implicate Glycoprotein VI as a Potential Drug Target for Cardioembolic Stroke in South Asian Populations. Wu S; Meena D; Yarmolinsky J; Gill D; Smith A; Dib MJ; Chauhan G; Rohatgi A; Dehghan A; Tzoulaki I J Am Heart Assoc; 2024 Aug; 13(16):e035008. PubMed ID: 39119976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]